In summary, FOXO4-DRI exerts its anti-aging effects by inhibiting the binding of FOXO4 to P53, promoting P53 phosphorylation, and facilitating the translocation of p-P53 from the nucleus to the cytoplasm for its functional role
Most GLOW research products are sold pre-blended with a 5:1:1 ratio (50 mg GHK-Cu, 10 mg TB-500, 10 mg BPC-157)
Therefore, 100 units = 1 mL
The metabolism and elimination of NAD+ (and its by-products) could be altered in advanced hepatic or renal dysfunction, and high-dose NAD+ might theoretically affect cardiovascular dynamics, so practitioners generally avoid or closely supervise NAD+ use in such settings
That statement surprises most people, but it is the foundational truth that shapes everything else in this guide